Ion Beam Applications SA
Nicolas Grek is currently an R&D hardware engineer at IBA, focusing on cyclotron-proton therapy since January 2024. From September 2021, Nicolas has been a senior process consultant at SThree while also serving as a supervisor of production at AbbVie from April 2023 to January 2024, managing routine operations for medical device production. Previous roles include support production and SAP integration at AbbVie, support production at Zoetis, and earlier positions in process engineering and team supervision at various companies including Vesuvius Ghlin and AkzoNobel. Nicolas also held the position of CEO at Shakease Corporation, leading a startup in the pharmaceutical medical device sector. Educational qualifications include a technician degree in chemistry and specialized training in biopharmacy.
This person is not in any teams
This person is not in any offices
Ion Beam Applications SA
4 followers
Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business segments, namely the pharmaceuticals segment, which includes radiopharmaceuticals and the equipments segment, which encompasses proton therapy, particle accelerators and dosimetry. Through its various subsidiaries, Ion Beam Applications SA is active in a number of countries, including Belgium, Germany, France, Italy, Spain, the United Kingdom, Sweden, the United States, India and China. In November 2013, the Company announced the closing of the sale of 100% of its business unit Cisbio Bioassays.